http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrenttruefalse0000830524--08-312023Q1YesYes94997049462765http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpensefalse0000830524us-gaap:CommonStockMember2021-09-012021-11-300000830524us-gaap:RetainedEarningsMember2022-11-300000830524us-gaap:AdditionalPaidInCapitalMember2022-11-300000830524us-gaap:AccumulatedTranslationAdjustmentMember2022-11-300000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-11-300000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-11-300000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-11-300000830524us-gaap:RetainedEarningsMember2022-08-310000830524us-gaap:AdditionalPaidInCapitalMember2022-08-310000830524us-gaap:AccumulatedTranslationAdjustmentMember2022-08-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-08-310000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-08-310000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-08-310000830524us-gaap:RetainedEarningsMember2021-11-300000830524us-gaap:AdditionalPaidInCapitalMember2021-11-300000830524us-gaap:AccumulatedTranslationAdjustmentMember2021-11-300000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-11-300000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-11-300000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-11-300000830524us-gaap:RetainedEarningsMember2021-08-310000830524us-gaap:AdditionalPaidInCapitalMember2021-08-310000830524us-gaap:AccumulatedTranslationAdjustmentMember2021-08-310000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-08-310000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-08-310000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-08-310000830524us-gaap:CommonStockMember2022-11-300000830524us-gaap:CommonStockMember2022-08-310000830524us-gaap:CommonStockMember2021-11-300000830524us-gaap:CommonStockMember2021-08-310000830524srt:ManagementMemberus-gaap:EmployeeStockOptionMemberccf:Longtermincentiveplan2022Member2022-08-310000830524srt:ManagementMemberccf:Longtermincentiveplan2022Memberccf:August2024VestingMember2021-08-310000830524srt:ManagementMemberus-gaap:EmployeeStockOptionMemberccf:Longtermincentiveplan2022Memberccf:August2024VestingMember2021-08-012021-08-310000830524srt:ManagementMemberccf:TimeBasedRestrictedStockMemberccf:LongTermIncentivePlan2023Memberccf:August312023VestingDateMember2022-08-012022-08-310000830524srt:ManagementMemberccf:TimeBasedRestrictedStockMemberccf:LongTermIncentivePlan2023Memberccf:August2025VestingMember2022-08-012022-08-310000830524srt:ManagementMemberccf:RetentionTimeBasedRestrictedStockMemberccf:LongTermIncentivePlan2023Memberccf:September2023VestingMember2022-08-012022-08-310000830524srt:ManagementMemberccf:RetentionTimeBasedRestrictedStockMemberccf:LongTermIncentivePlan2023Memberccf:March2023VestingMember2022-08-012022-08-310000830524srt:ManagementMemberccf:RetentionTimeBasedRestrictedStockMemberccf:LongTermIncentivePlan2023Memberccf:August2026VestingMember2022-08-012022-08-310000830524srt:ManagementMemberccf:RetentionTimeBasedRestrictedStockMemberccf:LongTermIncentivePlan2023Memberccf:August2024VestingMember2022-08-012022-08-310000830524srt:ManagementMemberccf:PerformanceAndServiceBasedRestrictedStockMemberccf:LongTermIncentivePlan2023Memberccf:August2025VestingMember2022-08-012022-08-310000830524srt:ManagementMemberccf:RetentionTimeBasedRestrictedStockMemberccf:LongTermIncentivePlan2023Member2022-08-012022-08-310000830524us-gaap:RestrictedStockMember2021-09-012022-08-310000830524srt:ManagementMemberccf:PerformanceAndServiceBasedRestrictedStockMemberccf:Longtermincentiveplan2022Memberccf:August2024VestingMember2021-08-012021-08-310000830524srt:NorthAmericaMemberccf:IndustrialTapesMember2022-09-012022-11-300000830524srt:NorthAmericaMemberccf:CorrosionProtectionAndWaterproofingMember2022-09-012022-11-300000830524srt:NorthAmericaMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524srt:EuropeMemberccf:IndustrialTapesMember2022-09-012022-11-300000830524srt:EuropeMemberccf:CorrosionProtectionAndWaterproofingMember2022-09-012022-11-300000830524srt:EuropeMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524ccf:OtherCountriesMemberccf:IndustrialTapesMember2022-09-012022-11-300000830524ccf:OtherCountriesMemberccf:CorrosionProtectionAndWaterproofingMember2022-09-012022-11-300000830524ccf:OtherCountriesMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524ccf:AsiaMiddleEastMemberccf:IndustrialTapesMember2022-09-012022-11-300000830524ccf:AsiaMiddleEastMemberccf:CorrosionProtectionAndWaterproofingMember2022-09-012022-11-300000830524ccf:AsiaMiddleEastMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524us-gaap:RoyaltyMember2022-09-012022-11-300000830524us-gaap:ProductMember2022-09-012022-11-300000830524srt:NorthAmericaMember2022-09-012022-11-300000830524srt:EuropeMember2022-09-012022-11-300000830524country:US2022-09-012022-11-300000830524country:GB2022-09-012022-11-300000830524country:FR2022-09-012022-11-300000830524ccf:OtherCountriesMember2022-09-012022-11-300000830524ccf:IndustrialTapesMember2022-09-012022-11-300000830524ccf:CorrosionProtectionAndWaterproofingMember2022-09-012022-11-300000830524ccf:AsiaMiddleEastMember2022-09-012022-11-300000830524ccf:AllOtherForeignMember2022-09-012022-11-300000830524srt:NorthAmericaMemberccf:IndustrialTapesMember2021-09-012021-11-300000830524srt:NorthAmericaMemberccf:CorrosionProtectionAndWaterproofingMember2021-09-012021-11-300000830524srt:NorthAmericaMemberccf:AdhesivesSealantsAndAdditivesMember2021-09-012021-11-300000830524srt:EuropeMemberccf:IndustrialTapesMember2021-09-012021-11-300000830524srt:EuropeMemberccf:CorrosionProtectionAndWaterproofingMember2021-09-012021-11-300000830524srt:EuropeMemberccf:AdhesivesSealantsAndAdditivesMember2021-09-012021-11-300000830524ccf:OtherCountriesMemberccf:IndustrialTapesMember2021-09-012021-11-300000830524ccf:OtherCountriesMemberccf:CorrosionProtectionAndWaterproofingMember2021-09-012021-11-300000830524ccf:OtherCountriesMemberccf:AdhesivesSealantsAndAdditivesMember2021-09-012021-11-300000830524ccf:AsiaMiddleEastMemberccf:IndustrialTapesMember2021-09-012021-11-300000830524ccf:AsiaMiddleEastMemberccf:CorrosionProtectionAndWaterproofingMember2021-09-012021-11-300000830524ccf:AsiaMiddleEastMemberccf:AdhesivesSealantsAndAdditivesMember2021-09-012021-11-300000830524us-gaap:RoyaltyMember2021-09-012021-11-300000830524us-gaap:ProductMember2021-09-012021-11-300000830524srt:NorthAmericaMember2021-09-012021-11-300000830524srt:EuropeMember2021-09-012021-11-300000830524country:US2021-09-012021-11-300000830524country:GB2021-09-012021-11-300000830524country:FR2021-09-012021-11-300000830524ccf:OtherCountriesMember2021-09-012021-11-300000830524ccf:IndustrialTapesMember2021-09-012021-11-300000830524ccf:CorrosionProtectionAndWaterproofingMember2021-09-012021-11-300000830524ccf:AsiaMiddleEastMember2021-09-012021-11-300000830524ccf:AllOtherForeignMember2021-09-012021-11-300000830524us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-11-300000830524us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-11-300000830524us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-08-310000830524us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-08-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-09-012022-11-300000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-09-012021-11-300000830524ccf:NuceraSolutionsMember2021-09-012022-08-3100008305242022-09-012022-09-010000830524ccf:WoburnMaMemberccf:AdhesivesSealantsAndAdditivesMember2021-09-012021-11-300000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-012022-11-300000830524us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-012021-11-300000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-012022-11-300000830524us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-012021-11-300000830524us-gaap:AccumulatedTranslationAdjustmentMember2022-09-012022-11-300000830524us-gaap:AccumulatedTranslationAdjustmentMember2021-09-012021-11-300000830524ccf:WoburnMaMember2022-09-012022-11-300000830524ccf:NuceraSolutionsMemberccf:SecondAmendedAndRestatedCreditAgreementMember2022-11-300000830524us-gaap:FairValueInputsLevel2Member2022-11-300000830524us-gaap:FairValueInputsLevel2Member2022-08-310000830524country:US2022-11-300000830524country:GB2022-11-300000830524country:FR2022-11-300000830524ccf:AllOtherForeignMember2022-11-300000830524country:US2022-08-310000830524country:GB2022-08-310000830524country:FR2022-08-310000830524ccf:AllOtherForeignMember2022-08-310000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-012022-11-300000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-09-012021-11-300000830524us-gaap:OperatingSegmentsMember2022-09-012022-11-300000830524us-gaap:CorporateNonSegmentMember2022-09-012022-11-300000830524us-gaap:OperatingSegmentsMember2021-09-012021-11-300000830524us-gaap:CorporateNonSegmentMember2021-09-012021-11-300000830524ccf:CorrosionProtectionAndWaterproofingMember2022-09-012022-11-300000830524ccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524ccf:NuceraSolutionsMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524ccf:IndustrialTapesMember2022-11-300000830524ccf:CorrosionProtectionAndWaterproofingMember2022-11-300000830524ccf:AdhesivesSealantsAndAdditivesMember2022-11-300000830524ccf:IndustrialTapesMember2022-08-310000830524ccf:CorrosionProtectionAndWaterproofingMember2022-08-310000830524ccf:AdhesivesSealantsAndAdditivesMember2022-08-310000830524us-gaap:OtherOperatingIncomeExpenseMember2022-09-012022-11-300000830524us-gaap:OtherOperatingIncomeExpenseMember2021-09-012021-11-300000830524us-gaap:TradeNamesMember2022-11-300000830524ccf:PatentsAndAgreementsMember2022-11-300000830524ccf:FormulasAndTechnologyMember2022-11-300000830524ccf:CustomerListsAndRelationshipsMember2022-11-300000830524us-gaap:TradeNamesMember2022-08-310000830524ccf:PatentsAndAgreementsMember2022-08-310000830524ccf:FormulasAndTechnologyMember2022-08-310000830524ccf:CustomerListsAndRelationshipsMember2022-08-310000830524us-gaap:RetainedEarningsMember2022-09-012022-11-300000830524us-gaap:RetainedEarningsMember2021-09-012021-11-300000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-012022-11-300000830524us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-012021-11-300000830524srt:MinimumMemberccf:SecondAmendedAndRestatedCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-07-272021-07-270000830524srt:MaximumMemberccf:SecondAmendedAndRestatedCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-07-272021-07-2700008305242022-11-102022-11-1000008305242021-11-3000008305242021-08-310000830524ccf:WoburnMaMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524ccf:WestwoodMaMember2022-09-012022-11-300000830524ccf:ErpSystemUpgradeMember2022-09-012022-11-300000830524ccf:EngineeringStudiesForFacilityConsolidationAndRationalizationInitiativeMember2022-09-012022-11-300000830524ccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524ccf:WestwoodMaMember2021-09-012021-11-300000830524ccf:AdhesivesSealantsAndAdditivesMember2021-09-012021-11-300000830524ccf:NuceraSolutionsMember2022-06-012022-08-310000830524us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-11-300000830524us-gaap:FairValueMeasurementsRecurringMember2022-11-300000830524ccf:AbchimeMember2022-11-300000830524us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-08-310000830524us-gaap:FairValueMeasurementsRecurringMember2022-08-310000830524ccf:AbchimeMember2020-09-010000830524ccf:NuceraSolutionsMember2021-09-012021-11-300000830524us-gaap:OperatingSegmentsMember2022-11-300000830524us-gaap:CorporateNonSegmentMember2022-11-300000830524ccf:IndustrialTapesMember2022-11-300000830524ccf:CorrosionProtectionAndWaterproofingMember2022-11-300000830524ccf:AdhesivesSealantsAndAdditivesMember2022-11-300000830524us-gaap:OperatingSegmentsMember2022-08-310000830524us-gaap:CorporateNonSegmentMember2022-08-310000830524ccf:IndustrialTapesMember2022-08-310000830524ccf:CorrosionProtectionAndWaterproofingMember2022-08-310000830524ccf:AdhesivesSealantsAndAdditivesMember2022-08-310000830524us-gaap:AdditionalPaidInCapitalMember2021-09-012021-11-300000830524us-gaap:OperatingSegmentsMemberccf:IndustrialTapesMember2022-09-012022-11-300000830524us-gaap:OperatingSegmentsMemberccf:CorrosionProtectionAndWaterproofingMember2022-09-012022-11-300000830524us-gaap:OperatingSegmentsMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524us-gaap:OperatingSegmentsMemberccf:IndustrialTapesMember2021-09-012021-11-300000830524us-gaap:OperatingSegmentsMemberccf:CorrosionProtectionAndWaterproofingMember2021-09-012021-11-300000830524us-gaap:OperatingSegmentsMemberccf:AdhesivesSealantsAndAdditivesMember2021-09-012021-11-3000008305242022-08-3100008305242022-12-310000830524srt:ManagementMemberus-gaap:EmployeeStockOptionMemberccf:Longtermincentiveplan2022Member2022-08-012022-08-310000830524srt:ManagementMemberccf:Longtermincentiveplan2022Memberccf:August2024VestingMember2021-08-012021-08-310000830524ccf:SecondAmendedAndRestatedCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-07-272021-07-270000830524us-gaap:AdditionalPaidInCapitalMember2022-09-012022-11-300000830524us-gaap:CommonStockMember2022-09-012022-11-300000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-012022-11-300000830524us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-09-012021-11-300000830524ccf:SecondAmendedAndRestatedCreditAgreementMember2021-07-2700008305242022-11-300000830524ccf:NuceraSolutionsMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-300000830524us-gaap:TradeNamesMember2022-09-012022-11-300000830524ccf:PatentsAndAgreementsMember2022-09-012022-11-300000830524ccf:FormulasAndTechnologyMember2022-09-012022-11-300000830524ccf:CustomerListsAndRelationshipsMember2022-09-012022-11-300000830524us-gaap:TradeNamesMember2021-09-012022-08-310000830524ccf:PatentsAndAgreementsMember2021-09-012022-08-310000830524ccf:FormulasAndTechnologyMember2021-09-012022-08-310000830524ccf:CustomerListsAndRelationshipsMember2021-09-012022-08-310000830524ccf:NuceraSolutionsMember2022-09-012022-09-010000830524ccf:SecondAmendedAndRestatedCreditAgreementMember2021-07-272021-07-270000830524ccf:SecondAmendedAndRestatedCreditAgreementMember2022-11-300000830524ccf:NuceraSolutionsMember2022-09-010000830524ccf:AbchimeMemberccf:AdhesivesSealantsAndAdditivesMember2022-09-012022-11-3000008305242022-09-012022-11-300000830524ccf:AbchimeMemberccf:AdhesivesSealantsAndAdditivesMember2021-09-012021-11-3000008305242021-09-012021-11-300000830524ccf:NuceraSolutionsMember2022-09-012022-11-30iso4217:USDxbrli:purexbrli:sharesccf:itemiso4217:EURiso4217:USDxbrli:sharesccf:segment

It

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended November 30, 2022

Commission File Number: 1-9852

CHASE CORPORATION

(Exact name of registrant as specified in its charter)

Massachusetts

11-1797126

(State or other jurisdiction of incorporation
of organization)

(I.R.S. Employer Identification No.)

375 University Avenue, Westwood, Massachusetts 02090

(Address of Principal Executive Offices) (Zip Code)

(781) 332-0700

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Common stock, $.10 par value

Trading Symbol(s)

CCF

Name of each exchange on which registered

NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. YES   NO 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  YES   NO 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES   NO 

The number of shares of Common Stock outstanding as of December 31, 2022 was 9,500,018.

CHASE CORPORATION

INDEX TO FORM 10-Q

For the Quarter Ended November 30, 2022

Ca

Cautionary Note Concerning Forward-Looking Statements

3

Part I - FINANCIAL INFORMATION

Item 1 – Unaudited Condensed Consolidated Financial Statements

Condensed Consolidated Balance Sheets as of November 30, 2022 (unaudited) and August 31, 2022

4

Condensed Consolidated Statements of Operations for the three months ended November 30, 2022 and 2021 (unaudited)

5

Condensed Consolidated Statements of Comprehensive Income for the three months ended November 30, 2022 and 2021 (unaudited)

6

Condensed Consolidated Statements of Equity for the three months ended November 30, 2022 and 2021 (unaudited)

7

Condensed Consolidated Statements of Cash Flows for the three months ended November 30, 2022 and 2021 (unaudited)

8

Notes to Unaudited Condensed Consolidated Financial Statements

9

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

33

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

44

Item 4 – Controls and Procedures

45

Part II – OTHER INFORMATION

Item 1 – Legal Proceedings

46

Item 1A – Risk Factors

46

Item 6 – Exhibits

46

SIGNATURES

47

2

Cautionary Note Concerning Forward-Looking Statements

This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, including without limitation forward-looking statements made under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” involve risks and uncertainties. Any statements contained in this Quarterly Report that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements include, without limitation, statements as to future operating results; seasonality expectations; plans for the development, utilization or disposal of manufacturing facilities; future economic conditions; our expectations as to legal proceedings; the effect of our market and product development efforts; and expectations or plans relating to the implementation or realization of our strategic goals and future growth, including through potential future acquisitions. Forward-looking statements may also include, among other things, statements relating to future sales, earnings, cash flow, results of operations, use of cash and other measures of financial performance, statements relating to future dividend payments, as well as the expected impact of the coronavirus disease 2019 (COVID-19) pandemic on the Company's businesses. Forward-looking statements may be identified through the use of words such as “believes,” “anticipates,” “may,” “should,” “will,” “plans,” “projects,” “expects,” “expectations,” “estimates,” “predicts,” “targets,” “forecasts,” “strategy,” and other words of similar meaning in connection with the discussion of future operating or financial performance. These statements are based on current expectations, estimates and projections about the industries in which we operate, and the beliefs and assumptions made by management. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Accordingly, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Investors should refer to the discussions under “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022, concerning certain factors that could cause our actual results to differ materially from the results anticipated in such forward-looking statements. These Risk Factors are hereby incorporated by reference into this Quarterly Report.

3

Item 1 — Unaudited Condensed Consolidated Financial Statements

CHASE CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

In thousands, except share and per share amounts

November 30, 

August 31, 

 

2022

    

2022

 

ASSETS

Current Assets

Cash and cash equivalents

$

56,317

$

315,495

Accounts receivable, less allowances of $666 and $610

58,166

51,540

Inventory

85,984

63,039

Prepaid expenses and other current assets

12,373

4,374

Prepaid income taxes and refunds due

1,902

2,329

Total current assets

214,742

436,777

Property, plant and equipment, less accumulated depreciation of $54,902 and $52,503

62,655

24,248

Other Assets

Goodwill

175,782

95,160

Intangible assets, less accumulated amortization of $109,968 and $101,237

173,757

33,661

Cash surrender value of life insurance

4,450

4,450

Restricted investments

2,540

2,367

Deferred income taxes

121

5,763

Operating lease right-of-use assets

8,249

8,596

Other assets

766

558

Total assets

$

643,062

$

611,580

LIABILITIES AND EQUITY

Current Liabilities

Accounts payable

$

23,570

$

20,122

Accrued payroll and other compensation

5,565

6,381

Income taxes payable

2,576

554

Accrued expenses

10,617

8,271

Dividend Payable

9,500

Total current liabilities

51,828

35,328

Long-term debt

165,000

180,000

Operating lease long-term liabilities

6,716

6,618

Deferred compensation

2,548

2,375

Accumulated pension obligation

7,181

7,431

Other liabilities

3,295

2,897

Deferred income taxes

31,544

2,282

Accrued income taxes

1,925

1,820

Total liabilities

$

270,037

$

238,751

Commitments and contingencies (Note 10)

Equity

First Serial Preferred Stock, $1.00 par value: Authorized 100,000 shares; none issued

Common stock, $.10 par value: Authorized 20,000,000 shares; 9,499,704 shares at November 30, 2022 and 9,462,765 shares at August 31, 2022 issued and outstanding

951

947

Additional paid-in capital

22,134

21,409

Accumulated other comprehensive loss

(18,124)

(20,367)

Retained earnings

368,064

370,840

Total equity

373,025

372,829

Total liabilities and equity

$

643,062

$

611,580

See accompanying notes to the unaudited condensed consolidated financial statements

4

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

In thousands, except share and per share amounts

Three Months Ended November 30, 

    

2022

    

2021

 

Revenue

Sales

$

102,121

$

74,192

Royalties and commissions

772

818

102,893

75,010

Costs and Expenses

Cost of products and services sold

67,000

47,281

Selling, general and administrative expenses

21,607

13,375

Research and product development costs

1,491

993

Operations optimization costs (Note 15)

653

59

Acquisition-related costs (Note 17)

29

Loss on impairment of right-of-use lease asset (Note 15)

548

Loss on contingent consideration (Note 17)

306

475

Operating income

11,259

12,827

Interest expense

(2,138)

(87)

Other income (expense)

(521)

377

Income before income taxes

8,600

13,117

Income taxes (Note 14)

1,876

3,390

Net income

$

6,724

$

9,727

Net income available to common shareholders, per common and common equivalent share (Note 4)

Basic

$

0.71

$

1.03

Diluted

$

0.71

$

1.02

Weighted average shares outstanding

Basic

9,417,418

9,397,873

Diluted

9,444,124

9,438,434

Annual cash dividends declared per share

$

1.00

$

1.00

See accompanying notes to the unaudited condensed consolidated financial statements

5

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

In thousands, except share and per share amounts

Three Months Ended November 30, 

    

2022

    

2021

 

 

Net income

$

6,724

    

$

9,727

Other comprehensive income (loss):

Net unrealized (loss) gain on restricted investments, net of tax

38

(30)

Change in funded status of pension plans, net of tax

112

112

Pension settlement loss, net of tax

150

Foreign currency translation adjustment

1,943

(2,173)

Total other comprehensive income (loss)

2,243

(2,091)

Comprehensive income

$

8,967

$

7,636

See accompanying notes to the unaudited condensed consolidated financial statements

6

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

THREE MONTHS ENDED NOVEMBER 30, 2022 AND 2021

(UNAUDITED)

 

In thousands, except share and per share amounts

Additional

Accumulated Other

Total

Common Stock

Paid-In

Comprehensive

Retained

Stockholders'

    

Shares

    

Amount

    

Capital

    

Income (Loss)

    

Earnings

    

Equity

Balance at August 31, 2021

9,447,905

$

946

$

18,959

$

(11,210)

$

335,629

$

344,324

Restricted stock grants, net of forfeitures

11,780

1

(1)

Amortization of restricted stock grants

556

556

Amortization of stock option grants

219

219

Cash dividend declared, $1.00 per share

(9,460)

(9,460)

Change in funded status of pension plans, net of tax $37

112

112

Foreign currency translation adjustment

(2,173)

(2,173)

Net unrealized gain (loss) on restricted investments, net of tax ($10)

(30)

(30)

Net income

9,727

9,727

Balance at November 30, 2021

9,459,685

$

947

$

19,733

$

(13,301)

$

335,896

$

343,275

Balance at August 31, 2022

9,462,765

$

947

$

21,409

$

(20,367)

$

370,840

$

372,829

Restricted stock grants, net of forfeitures

30,307

3

(3)

Amortization of restricted stock grants

832

832

Amortization of stock option grants

126

126

Exercise of stock options

15,152

2

555

557

Common stock received for payment of stock option exercises

(6,140)

(1)

(556)

(557)

Common stock retained to pay statutory minimum withholding taxes on common stock

(2,380)

(229)

(229)

Cash dividend declared, $1.00 per share

(9,500)

(9,500)

Change in funded status of pension plans, net of tax $37

112

112

Pension settlement loss, net of tax $50

150

150

Foreign currency translation adjustment

1,943

1,943

Net unrealized gain (loss) on restricted investments, net of tax $14

38

38

Net income

6,724

6,724

Balance at November 30, 2022

9,499,704

$

951

$

22,134

$

(18,124)

$

368,064

$

373,025

See accompanying notes to the unaudited condensed consolidated financial statements

7

CHASE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

In thousands

Three Months Ended

    

November 30, 2022

    

November 30, 2021

 

CASH FLOWS FROM OPERATING ACTIVITIES

Net income

$

6,724

$

9,727

Adjustments to reconcile net income to net cash provided by operating activities

Loss on impairment of right-of-use lease asset

548

Loss on contingent consideration

306

475

Depreciation

2,330

877

Amortization

8,400

3,125

Provision for allowance for doubtful accounts

54

(40)

Stock-based compensation

958

775

Realized gain on restricted investments

(7)

(7)

Pension curtailment and settlement loss

150

Deferred taxes

(2,008)

34

Increase (decrease) from changes in assets and liabilities

Accounts receivable

4,019

2,272

Inventory

(6,636)

(6,021)

Prepaid expenses and other assets

(2,746)

(1,331)

Accounts payable

(1,482)

(2,024)

Accrued compensation and other expenses

(5,578)

(2,254)

Accrued income taxes

1,726

295

Net cash provided by operating activities

6,758

5,903

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property, plant and equipment

(2,052)

(496)

Payments for acquisitions, net of cash acquired

(248,967)

Changes in restricted investments

(114)

(121)

Net cash (used in) provided by investing activities

(251,133)

(617)

CASH FLOWS FROM FINANCING ACTIVITIES

Payments of principal on debt

(15,000)

Payments of taxes on stock options and restricted stock

(229)

Net cash (used in) provided by financing activities

(15,229)

(DECREASE) INCREASE IN CASH & CASH EQUIVALENTS

(259,604)

5,286

Effect of foreign exchange rates on cash

426

(481)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

315,495

119,429

CASH AND CASH EQUIVALENTS, END OF PERIOD

$

56,317

$

124,234

Non-cash Investing and Financing Activities

Common stock received for payment of stock option exercises

$

557

$

Property, plant and equipment additions included in accounts payable

$

246

$

207

Annual cash dividend declared

$

9,500

$

9,460

Purchase price final working capital adjustment

$

480

$

See accompanying notes to the unaudited condensed consolidated financial statements

8

CHASE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

In thousands, except share and per share amounts

Note 1 — Basis of Financial Statement Presentation

Description of Business

Chase Corporation (the “Company,” “Chase,” “we,” or “us”), a global specialty chemicals company founded in 1946, is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors. The Company’s strategy is to maximize the performance of its core businesses and brands while seeking future opportunities through strategic acquisitions. Through investments in facilities, systems and organizational consolidation, the Company seeks to improve performance and gain economies of scale.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States of America generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting, and with the rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Therefore, they do not include all information and footnote disclosures necessary for a complete presentation of Chase Corporation’s financial position, results of operations and cash flows. The year-end condensed balance sheet was derived from audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. Chase Corporation filed audited consolidated financial statements which included all information and notes necessary for such a complete presentation for the three years ended August 31, 2022 in conjunction with its 2022 Annual Report on Form 10-K. Certain immaterial reclassifications have been made to the prior year amounts to conform to the current year’s presentation.

Unless otherwise indicated, all references to a year mean our fiscal year, which ends on August 31.

The results of operations for the interim period ended November 30, 2022 are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended August 31, 2022 which are contained in the Company’s 2022 Annual Report on Form 10-K.

The accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring items) that are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of November 30, 2022, and the results of its operations, comprehensive income, changes in equity and cash flows for the interim periods ended November 30, 2022 and 2021.

The financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company uses the U.S. dollar as the reporting currency for financial reporting. The financial position and results of operations of the Company’s U.K.-based operations are measured using the British pound as the functional currency. The financial position and results of operations of the Company’s operations based in France, including the operations of NuCera Solutions in France, are measured using the euro as the functional currency. The financial position and results of the Company’s HumiSeal India Private Limited business are measured using the Indian rupee as the functional currency. The financial position and results of operations of the NuCera Solutions operations in Singapore are measured using the Singapore dollar as the functional currency. The functional currency for all of the Company’s other operations is the U.S. dollar. Foreign currency translation gains and losses are determined using current exchange rates for monetary items and historical exchange rates for other balance sheet items and are recorded as a change in other comprehensive income. Transaction gains and losses generated from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of each applicable operation are included in other income (expense) on the condensed consolidated

9

statements of operations, and were $(199) and $241 for the three-month periods ended November 30, 2022 and 2021, respectively.

10

Other Business Developments

On September 1, 2022 (the first day of fiscal 2023), the Company acquired all of the capital stock of NuCera Solutions (“NuCera”) for a purchase price of $250,000, net of debt, accrued income taxes and cash at closing, and working capital adjustments. The purchase was funded by utilizing $180,000 from the Company’s existing revolving credit facility and the remaining $70,000 from available cash on hand. The Company recorded transaction costs of $29 in the first quarter of fiscal 2023 and $4,000 in the fourth quarter of fiscal 2022 related to this acquisition which are excluded from the purchase price. NuCera is a recognized global leader in the production and development of highly differentiated specialty polymers and polymerization technologies serving demanding applications, offering products critical to enabling end-product functionality, performance and reliability. Chase will continue to market under NuCera brands and the business is integrated into Chase’s Adhesives, Sealants and Additives reporting unit for fiscal 2023.

During the first quarter of fiscal 2023, the Company began the process of upgrading our current Oracle Legacy ERP System to the Oracle Fusion Cloud Platform. This upgrade will position us with a more advanced system to support business expansion, access to upgrades in functionality and a more modern system for operations. Additionally, the upgrade will be a multi-year, phased-in approach designed to mitigate any disruptions to our business. The Company recognized $540 in expense related to the ERP System upgrade in the first quarter of fiscal 2023.

During the third quarter of fiscal 2021 Chase announced to the employees at its Woburn, MA location that its adhesives systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, would be consolidating into the Company’s existing O'Hara Township, PA location. Chase Corporation obtained the adhesives systems operations as part of its fiscal 2017 acquisition of the operations of Resin Designs. The Company expensed $113 and $0 related to the consolidation of the Woburn, MA location during the first quarters of fiscal 2023 and 2022, respectively. In addition, the Company expensed $548 as a lease impairment related to the Woburn, MA facility relocation in the first quarter of 2023. The Company may have additional costs related to the lease termination in future periods.

The Company completed the relocation of its corporate headquarters to another location within Westwood, MA during the fiscal year ending August 31, 2022. The move, part of the Company’s ongoing consolidation and optimization initiative, capitalizes on the hybrid work model utilized by many of Chase’s corporate and administrative employees and is expected to provide future operational cost savings. The new facility also consolidates and houses research and development operations previously conducted at the previous Westwood, MA and Woburn, MA locations. Operations optimization costs related to the Westwood move of $59 were expensed in the first quarter of fiscal 2022. The relocation of its corporate headquarters is complete and no costs are expected in fiscal 2023.

11

Significant Accounting Policies

The Company’s significant accounting policies are detailed in Note 1 — “Summary of Significant Accounting Policies” within Item 8 of the Company’s Annual Report on Form 10-K for the year ended August 31, 2022. See Note 2 of the condensed consolidated financial statements for a discussion of the effects of recently issued accounting pronouncements.

12

Note 2 — Recent Accounting Standards

Recently Adopted Accounting Pronouncements - Fiscal 2023

No new Accounting Pronouncements were adopted in the first quarter of fiscal 2023.

Recently Adopted Accounting Pronouncements - Fiscal 2022

In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which amends the accounting for contract assets and contract liabilities from revenue contracts with customers in a business combination. The amendment requires that an entity acquiring the contract assets and contract liabilities in a business combination be recognized in accordance with ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. The ASU is effective for all public entities for fiscal years beginning after December 15, 2022, and interim periods therein. The Company early adopted ASU 2021-08 on February 28, 2022 and any impact on the consolidated financial statements will depend on the magnitude and nature of customer contracts associated with entities that the Company may acquire in the future.

Note 3 — Inventory

Inventory consisted of the following as of November 30, 2022 and August 31, 2022:

November 30, 

August 31, 

    

    

2022

    

2022

Raw materials

$

47,270

$

37,909

Work in process

9,695

9,569

Finished goods

29,019

15,561

Total Inventory

$

85,984

$

63,039

13

Note 4 — Net Income Per Share

The Company has unvested share-based payment awards with a right to receive nonforfeitable dividends which are considered participating securities under ASC Topic 260, “Earnings Per Share.” The Company allocates earnings to participating securities and computes earnings per share using the two-class method. The determination of earnings per share under the two-class method is as follows:

Three Months Ended November 30, 

    

2022

    

2021

    

Basic Earnings per Share

Net income

 

$

6,724

 

$

9,727

 

Less: Allocated to participating securities

56

64

Net income available to common shareholders

 

$

6,668

 

$

9,663

 

Basic weighted average shares outstanding

9,417,418

9,397,873

Net income per share - Basic

 

$

0.71

 

$

1.03

 

Diluted Earnings per Share

Net income

 

$

6,724

 

$

9,727

 

Less: Allocated to participating securities

56

64

Net income available to common shareholders

 

$

6,668

 

$

9,663

 

Basic weighted average shares outstanding

9,417,418

9,397,873

Additional dilutive common stock equivalents

26,706

40,561

Diluted weighted average shares outstanding

9,444,124

9,438,434

Net income per share - Diluted

 

$

0.71

 

$

1.02

 

Included in the calculation of dilutive common stock equivalents are the unvested portion of restricted stock and stock options. For the three-month periods ended November 30, 2022 and 2021, stock options to purchase 129,295 and 72,690 shares of common stock, respectively, were outstanding but were not included in the calculation of diluted income per share because their inclusion would be anti-dilutive.

14

Note 5 — Stock-Based Compensation

In August 2021, the Board of Directors of the Company approved the fiscal year 2022 Long Term Incentive Plan (“2022 LTIP”) for the executive officers and other members of management. The 2022 LTIP is an equity-based plan with a grant date of September 1, 2021 and contains (a) a restricted stock grant of 9,584 shares in the aggregate (of which 3,304 included a performance-based vesting component and were subject to adjustment as discussed below), with a vesting date of August 31, 2024, and (b) options to purchase 12,942 shares of common stock in the aggregate with an exercise price of $114.50 per share, vesting in three equal annual installments ending on August 31, 2024.

Based on the fiscal year 2022 results, 842 shares of restricted stock were forfeited subsequent to the end of fiscal year 2022 in accordance with not meeting the performance measurement criteria. No further performance-based measurements apply to this award.

In August 2022, the Board of Directors of the Company approved the fiscal year 2023 Long Term Incentive Plan (“2023 LTIP”) for executive officers and other members of management. The 2023 LTIP is an equity-based plan with a grant date of September 1, 2022 and contains the following equity components:

Restricted Shares — (a) a performance and service-based restricted stock grant of 10,580 shares in the aggregate, subject to adjustment based on fiscal 2023 results, with a vesting date of August 31, 2025. Compensation expense is recognized on a ratable basis over the vesting period based on quarterly probability assessments; and (b) a time-based restricted stock grant of 9,918 shares and 636 shares, with a vesting date of August 31, 2025 and August 31, 2023, respectively. Compensation expense is being recognized on a ratable basis over the vesting period. Additionally, the Board of Directors approved a retention grant of time-based restricted stock grant of 10,015 shares in the aggregate. Out of the 10,015 shares of granted time-based restricted stock, 2,056 shares vest on March 1, 2023, 3,705 shares vest on September 1, 2023, 1,418 shares vest on August 31, 2024, and 2,836 shares vest on August 31, 2026. Compensation expense is being recognized on a ratable basis over the vesting period.

Stock Options — options to purchase 25,987 shares of common stock in the aggregate with an exercise price of $88.16 per share. The options will vest in three equal annual installments beginning on August 31, 2023 and ending on August 31, 2025. The options will expire ten years after the grant date. Compensation expense is being recognized over the period of the award consistent with the vesting terms.

15

Note 6 — Segment Data and Foreign Operations

The Company is organized into three reportable operating segments: Adhesives, Sealants and Additives; Industrial Tapes; and Corrosion Protection and Waterproofing. The segments are distinguished by the nature of the products manufactured and how they are delivered to their respective markets.

The Adhesives, Sealants and Additives segment offers innovative and specialized product offerings consisting of both end-use products and intermediates that are used in, or integrated into, another company’s product. Demand for the segment’s product offerings is typically dependent upon general economic conditions. The Adhesives, Sealants and Additives segment leverages the core specialty chemical competencies of the Company and serves diverse markets and applications. The segment sells predominantly into the transportation, appliances, medical, general industrial and environmental market verticals. The segment’s products include moisture protective coatings and cleaners, customized sealant and adhesive systems for electronics, synthesized specialty waxes and polymers, polymeric microspheres, polyurethane dispersions and superabsorbent polymers. Beginning September 1, 2022, the Adhesives, Sealants and Additives segment includes the acquired operations of NuCera, within the functional additives product line.

The Industrial Tapes segment features wire and cable materials, specialty tapes and other laminated and coated products. The segment derives its competitive advantage through its proven chemistries, its diverse specialty offerings and the reliability its supply chain offers to end customers. These products are generally used in the assembly of other manufacturers’ products, with demand typically dependent upon general economic conditions. The Industrial Tapes segment sells mostly to established markets, with some exposure to growth opportunities through further development of existing products. Markets served include wire and cable manufacturing, utilities and telecommunications, and electronics packaging. The segment’s offerings include insulating and conducting materials for wire and cable manufacturers; laminated durable papers; laminates for the packaging and industrial laminate markets; custom manufacturing services; pulling and detection tapes used in the installation, measurement and location of fiber optic cables and water and natural gas lines; and cover tapes essential to delivering semiconductor components via tape-and-reel packaging.

The Corrosion Protection and Waterproofing segment is principally composed of project-oriented product offerings that are primarily sold and used as “Chase” branded products. End markets include new and existing infrastructure projects on oil, gas, water and wastewater pipelines, highways and bridge decks, water and wastewater containment systems, and commercial and industrial structures. The segment’s products include protective coatings for pipeline applications, coating and lining systems for waterproofing and liquid storage applications, adhesives and sealants used in architectural and building envelope waterproofing applications, high-performance polymeric asphalt additives, and expansion joint systems for waterproofing applications in transportation and architectural markets. With sales generally dependent on outdoor project work, the segment experiences highly seasonal sales patterns.

16

The following tables summarize information about the Company’s reportable segments:

Three Months Ended November 30, 

2022

    

2021

    

 

Revenue

Adhesives, Sealants and Additives

$

55,553

$

31,049

Industrial Tapes

39,077

32,761

Corrosion Protection and Waterproofing

8,263

11,200

Total

$

102,893

$

75,010

Income before income taxes

Adhesives, Sealants and Additives

$

4,124

(a)

$

7,597

(c)

Industrial Tapes

11,947

9,290

Corrosion Protection and Waterproofing

2,551

4,446

Total for reportable segments

18,622

21,333

Corporate and common costs

(10,022)

(b)

(8,216)

(d)

Total

$

8,600

$

13,117

Includes the following costs by segment:

Adhesives, Sealants and Additives

Interest

$

2,138

$

35

Depreciation

1,684

243

Amortization

8,398

2,740

Industrial Tapes

Interest

$

$

35

Depreciation

339

410

Amortization

1

384

Corrosion Protection and Waterproofing

Interest

$

$

17

Depreciation

125

118

Amortization

1

1

(a) Includes $306 loss on the upward adjustment of the performance-based earn out contingent consideration associated with the September 2020 acquisition of ABchimie, $113 in operations optimization costs related to the move from Woburn, MA to O’Hara Township, PA, $548 of lease impairment related to the Woburn, MA facility relocation, $2,200 of purchase accounting inventory adjustment related to the Company’s NuCera business, and $2,820 of backlog amortization fully amortized related to the Company’s NuCera business
(b) Includes $540 of operations optimization related to the Company’s ERP upgrade
(c) Includes $475 loss on the upward adjustment of the performance-based earn out contingent consideration associated with the September 2020 acquisition of ABchimie
(d) Includes $59 of operations optimization costs related to the Company’s move to the new corporate headquarters in Westwood, MA

17

Total assets for the Company’s reportable segments as of November 30, 2022 and August 31, 2022 were as follows:

November 30, 

August 31, 

    

2022

    

2022

 

 

Total Assets

Adhesives, Sealants and Additives

$

443,209

$

153,784

Industrial Tapes

91,078

87,751

Corrosion Protection and Waterproofing

30,821

33,037

Total for reportable segments

565,108

274,572

Corporate and common assets (a)

77,954

337,008

Total

$

643,062

$

611,580

(a) Corporate and common assets at August 31, 2022 include $180,000 in cash drawn from the Company’s revolving credit facility and $70,000 of cash on hand in anticipation of the acquisition of NuCera, which closed on the first day of fiscal year 2023.

The Company’s products are sold worldwide. Revenue for the three-month periods ended November 30, 2022 and 2021 was attributed to operations located in the following countries:

Three Months Ended November 30, 

2022

    

2021

Revenue

United States

$

87,161

$

65,053

United Kingdom

5,803

4,594

France

7,213

2,531

All other foreign (1)

2,716

2,832

Total

$

102,893

$

75,010

(1) Consists of sales from royalty revenue attributable to its licensed manufacturer in Asia and sales originated from the Company’s foreign operations in China, India and Singapore.

18

As of November 30, 2022 and August 31, 2022 the Company had long-lived assets (defined as tangible assets providing the Company with a future economic benefit beyond the current year or operating period, including buildings, equipment and leasehold improvements) and goodwill and intangible assets, less accumulated amortization, in the following countries:

November 30, 

August 31, 

2022

    

2022

Long-Lived Assets

United States

Property, plant and equipment, net

$

59,680

$

21,300

Goodwill and Intangible assets, less accumulated amortization

315,886

105,216

United Kingdom

Property, plant and equipment, net

1,827

1,832

Goodwill and Intangible assets, less accumulated amortization

3,402

3,318

France

Property, plant and equipment, net

267

239

Goodwill and Intangible assets, less accumulated amortization

29,606

20,130

All other foreign

Property, plant and equipment, net

881

877

Goodwill and Intangible assets, less accumulated amortization

645

157

Total

Property, plant and equipment, net

$

62,655

$

24,248

Goodwill and Intangible assets, less accumulated amortization

$

349,539

$

128,821

19

Note 7 — Goodwill and Other Intangibles

The changes in the carrying value of goodwill were as follows:

    

Adhesives, Sealants and Additives

    

Industrial Tapes

    

Corrosion Protection and Waterproofing

    

Consolidated

 

Balance at August 31, 2022

$

63,272

$

21,215

$

10,673

$

95,160

Acquisition of NuCera Solutions

80,041

80,041

Foreign currency translation adjustment

576

5

581

Balance at November 30, 2022

$

143,889

$

21,215

$

10,678

$

175,782

The Company’s goodwill is allocated to each reporting unit based on the nature of the products manufactured by the respective business combinations that originally created the goodwill. The Company has identified a total of three reporting units, corresponding to its three operating segments, that are used to evaluate the possible impairment of goodwill. Assessments of possible impairment of goodwill are made when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable through future operations. Additionally, testing for possible impairment of recorded goodwill and certain intangible asset balances is required annually. The amount and timing of any impairment charges based on these assessments require the estimation of future cash flows and the fair market value of the related assets based on management’s best estimates of certain key factors, including future selling prices and volumes; operating, raw material and energy costs; and various other projected operating and economic factors. When testing, fair values of the reporting units are established using discounted cash flows. The Company evaluates the possible impairment of goodwill annually, and whenever events or circumstances indicate the carrying value of goodwill may not be recoverable.

The Company has adopted ASU No. 2017-04 “Intangibles - Goodwill and Other Topics (Topic 350): Simplifying the Test for Goodwill Impairment.” The Company assesses goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount. If the fair value of a reporting unit is less than its carrying value, an impairment loss, limited to the amount of goodwill allocated to that reporting unit, is recorded.

Intangible assets subject to amortization consisted of the following as of November 30, 2022 and August 31, 2022:

Weighted Average

Gross Carrying

Accumulated

Net Carrying

    

Amortization Period

    

Value

    

Amortization

    

Value

 

November 30, 2022

Patents and agreements

14.6

years  

$

1,760

$

1,726

$

34

Formulas and technology

7.9

years  

24,172

10,456

13,716

Trade names

6.3

years  

14,798

8,678

6,120

Customer lists and relationships

11.0

years  

242,995

89,108

153,887

$

283,725

$

109,968

$

173,757

August 31, 2022

Patents and agreements

14.6

years  

$

1,760

$

1,724

$

36

Formulas and technology

7.8

years  

10,730

9,961

769

Trade names

5.9

years  

8,673

8,407

266

Customer lists and relationships

9.1

years  

113,735

81,145

32,590